174 related articles for article (PubMed ID: 9126700)
21. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
Singlas E
Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
[TBL] [Abstract][Full Text] [Related]
22. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
Basoli A; Meli EZ; Mazzocchi P; Speranza V
Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
[TBL] [Abstract][Full Text] [Related]
23. Using imipenem and cilastatin during continuous renal replacement therapy.
Cotton A; Franklin BD; Brett S; Holmes A
Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
Thalhammer F; Hörl WH
Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
[TBL] [Abstract][Full Text] [Related]
25. Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.
Balfour JA; Bryson HM; Brogden RN
Drugs; 1996 Jan; 51(1):99-136. PubMed ID: 8741235
[TBL] [Abstract][Full Text] [Related]
26. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
Edwards SJ; Emmas CE; Campbell HE
Curr Med Res Opin; 2005 May; 21(5):785-94. PubMed ID: 15969878
[TBL] [Abstract][Full Text] [Related]
27. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin.
Maggioni P; Di Stefano F; Facchini V; Irato S; Mancuso S; Colombo M; Massobrio M; Melis GB; Crosignani P
J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636
[TBL] [Abstract][Full Text] [Related]
28. Meropenem, a new carbapenem antibiotic.
Fish DN; Singletary TJ
Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
[TBL] [Abstract][Full Text] [Related]
29. Laboratory data which differentiate meropenem and imipenem.
Edwards JR; Turner PJ
Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504
[TBL] [Abstract][Full Text] [Related]
30. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
Pastel DA
Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
[TBL] [Abstract][Full Text] [Related]
31. The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.
Drusano GL; Standiford HC; Bustamante CI; Forrest A; Rivera G; Tatem B; Schimpff SC
Eur J Clin Microbiol; 1984 Oct; 3(5):468-70. PubMed ID: 6594235
[TBL] [Abstract][Full Text] [Related]
32. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
[TBL] [Abstract][Full Text] [Related]
33. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group.
Geroulanos SJ
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation.
Lomaestro BM; Drusano GL
Antimicrob Agents Chemother; 2005 Jan; 49(1):461-3. PubMed ID: 15616337
[TBL] [Abstract][Full Text] [Related]
35. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill.
Hashimoto S; Honda M; Yamaguchi M; Sekimoto M; Tanaka Y
ASAIO J; 1997; 43(1):84-8. PubMed ID: 9116359
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
Hamacher J; Vogel F; Lichey J; Kohl FV; Diwok K; Wendel H; Lode H
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():121-33. PubMed ID: 8543488
[TBL] [Abstract][Full Text] [Related]
39. Imipenem-cilastatin: the first thienamycin antibiotic.
Jacobs RF
Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
[No Abstract] [Full Text] [Related]
40. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].
Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H
Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
